Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Mohammadi, Hamed  [Clear All Filters]
2021
Navashenaq JGholizadeh, Shabgah AGowhari, Hedayati-Moghadam M, Ariaee N, Mohammadi H, Hemmatzadeh M, Azhdari S, Jamialahmadi T, Sathyapalan T, Sahebkar A. The role of myeloid-derived suppressor cells in rheumatoid arthritis: An update. Life Sci. 2021:119083.
2020
Salimifard S, Masjedi A, Hojjat-Farsangi M, Ghalamfarsa G, Irandoust M, Azizi G, Mohammadi H, Keramati MReza, Jadidi-Niaragh F. Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer. Pathol Res Pract. 2020:152915.
Nikkhoo A, Rostami N, Farhadi S, Esmaily M, Ardebili SMoghadasza, Atyabi F, Baghaei M, Haghnavaz N, Yousefi M, Aliparasti MReza, et al. Codelivery of STAT3 siRNA and BV6 by carboxymethyl dextran trimethyl chitosan nanoparticles suppresses cancer cell progression. Int J Pharm. 2020:119236.
Pourmoghadam Z, Soltani-Zangbar MSadegh, Sheikhansari G, Azizi R, Eghbal-Fard S, Mohammadi H, Siahmansouri H, Aghebati-Maleki L, Danaii S, Mehdizadeh A, et al. Intrauterine administration of autologous hCG- activated peripheral blood mononuclear cells improves pregnancy outcomes in patients with recurrent implantation failure; A double-blind, randomized control trial study. J Reprod Immunol. 2020;142:103182.
Hashemi V, Farhadi S, Chaleshtari MGhasemi, Seashore-Ludlow B, Masjedi A, Hojjat-Farsangi M, Namdar A, Ajjoolabady A, Mohammadi H, Ghalamfarsa G, et al. Nanomedicine for improvement of dendritic cell-based cancer immunotherapy. Int Immunopharmacol. 2020;83:106446.
Shabgah AGowhari, Salmaninejad A, Thangavelu L, Alexander M, Yumashev AValerievic, Goleij P, Hedayati-Moghadam M, Mohammadi H, Ahmadi M, Navashenaq JGholizadeh. The role of non-coding genome in the behavior of infiltrated myeloid-derived suppressor cells in tumor microenvironment; a perspective and state-of-the-art in cancer targeted therapy. Prog Biophys Mol Biol. 2020.
2019
Hassannia H, Chaleshtari MGhasemi, Atyabi F, Nosouhian M, Masjedi A, Hojjat-Farsangi M, Namdar A, Azizi G, Mohammadi H, Ghalamfarsa G, et al. Blockage of immune checkpoint molecules increases T cell priming potential of dendritic cell vaccine. Immunology. 2019.
Habibi S, Zaki-Dizaji M, Rafiemanesh H, Lo B, Jamee M, Gámez-Díaz L, Salami F, Kamali AN, Mohammadi H, Abolhassani H, et al. Clinical, immunologic, and molecular spectrum of patients with LPS-responsive beige-like anchor protein (LRBA) deficiency: a systematic review. J Allergy Clin Immunol Pract. 2019.
S Hosseini H, Sharafkandi N, Seyfizadeh N, Hemmatzadeh M, Marofi F, Shomali N, Karimi M, Mohammadi H. Progression or suppression: Two sides of the innate lymphoid cells in cancer. J Cell Biochem. 2019.